Kodiak Sciences
KODBiological Products, (No Disgnostic Substances) · Avg daily volume 2.0M · fiscal year ends Dec$91.32+1.72+1.92%Volume 1.0M−50% vs avg
10-day20-day50-day200-dayRS line vs S&P 500▲ earnings filed, EPS vs a year agoQ3 EPS due in ~16 days
2026-10-27O 89.65 H 94.73 L 89.20 C 91.32 (+1.92%)Vol 1.0M10 88.1320 91.5650 60.20200 41.03RS line 11.9RS rating 99
| FY (Dec) | EPS $ | Chg | High | Low |
|---|---|---|---|---|
| 2020 | -2.91 | – | – | – |
| 2021 | -5.16 | −77% | – | – |
| 2022 | -6.39 | −24% | – | – |
| 2023 | -4.97 | +22% | – | – |
| 2024 | -3.35 | +33% | 12 | 2 |
| 2025 | -4.32 | −29% | 31 | 2 |
| TTM | -4.19 | 104 | 16 |
Ratings & facts
RS Rating99
Days at RS 90+22
Setup checks3 / 3
EPS chg, last qtr−2%
EPS acceleratingno
Sales chg, last qtr–
P/E (last 4 qtrs)–
Mkt cap$5.74B
Off 52-wk high-12.2%
Quarterly earnings
Latest filing: 10-Q, 2026-08-13Mar ’24FQ1 ’24
Jun ’24FQ2 ’24
Sep ’24FQ3 ’24
Dec ’24Q4FQ4 ’24
Mar ’25FQ1 ’25
Jun ’25FQ2 ’25
Sep ’25FQ3 ’25
Dec ’25Q4FQ4 ’25
Mar ’26FQ1 ’26
Jun ’26FQ2 ’26
EPS
EPS
−$0.82
−$0.86
−$0.84
−$0.84
−$1.09
−$1.03
−$1.16
−$1.04
−$0.94
−$1.05
% chg
+39%
+44%
+12%
+26%
−33%
−20%
−38%
−24%
+14%
−2%
Sales
–
–
–
–
–
–
–
–
–
–
% chg
–
–
–
–
–
–
–
–
–
–
Filed
05/15
08/14
11/14
03/27
05/14
08/13
11/13
03/31
05/07
08/13
EPS growth ≥ 25%0–25%fallingno comparison
Source: SEC EDGAR 10-Q and 10-K filings, loaded the first time a stock is opened and refreshed daily. Q4 = full year minus the first three quarters. Growth from a loss is measured against the size of the loss (−$1 → $2 = +300%). Analyst estimates are not in EDGAR.